Table 2 Age and gender of healthy controls (controls) and uveitis patients (uveitis) stratified by the particular therapy.

From: PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease

 

Total

Mean Age (yrs)

Age St Dev (yrs)

Gender (M)

Gender (F)

IMT

14

50.3

11.6

8

6

Biologics

8

44.9

14.3

6

2

Biologics + IMT

8

42.9

15.8

2

6

Steroids + IMT + Biologics + NSAIDs

11

48.7

13.4

4

7

None

4

64.3

9.4

1

3

  1. Immunonomodulatory therapy (IMT) – methotrexate, cellcept, cyclosporine. Biologics – rituximab, adalimumab, infliximab. Non-Steroidal Anti-Inflammatory Drug (NSAID) – bromfenac. Steroids – difluprednate ophthalmic emulsion, prednisolone acetate ophthalmic suspension, loteprednol etabonate ophthalmic suspension.
Back to article page